Literature DB >> 27460397

Clinical guides for atypical hemolytic uremic syndrome in Japan.

Hideki Kato1, Masaomi Nangaku1, Hiroshi Hataya2, Toshihiro Sawai3, Akira Ashida4, Rika Fujimaru5, Yoshihiko Hidaka6, Shinya Kaname7, Shoichi Maruyama8, Takashi Yasuda9, Yoko Yoshida1, Shuichi Ito10, Motoshi Hattori11, Yoshitaka Miyakawa12, Yoshihiro Fujimura13, Hirokazu Okada14, Shoji Kagami15.   

Abstract

Atypical hemolytic uremic syndrome (aHUS) is a rare disease characterized by the triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury. In 2013, we developed diagnostic criteria to enable early diagnosis and timely initiation of appropriate treatment for aHUS. Recent clinical and molecular findings have resulted in several proposed classifications and definitions of thrombotic microangiopathy and aHUS. Based on recent advances in this field and the emerging international consensus to exclude secondary TMAs from the definition of aHUS, we have redefined aHUS and proposed diagnostic algorithms, differential diagnosis, and therapeutic strategies for aHUS.
© 2016 Japan Pediatric Society and Japanese Society of Nephrology.

Entities:  

Keywords:  alternative complement pathway; atypical hemolytic uremic syndrome; eculizumab; thrombotic microangiopathy

Mesh:

Year:  2016        PMID: 27460397     DOI: 10.1111/ped.13044

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  4 in total

Review 1.  Atypical hemolytic uremic syndrome and eculizumab therapy in children.

Authors:  Seong Heon Kim; Hye Young Kim; Su Young Kim
Journal:  Korean J Pediatr       Date:  2018-02-28

2.  Long-term Eculizumab Treatment Contributes to Recovery from End-stage Renal Disease Caused by Atypical Hemolytic Uremic Syndrome.

Authors:  Yuji Yamada; Ryohei Abe; Yutaka Okano; Yoshitaka Miyakawa
Journal:  Intern Med       Date:  2017-05-01       Impact factor: 1.271

Review 3.  Differences and similarities between disseminated intravascular coagulation and thrombotic microangiopathy.

Authors:  Hideo Wada; Takeshi Matsumoto; Kei Suzuki; Hiroshi Imai; Naoyuki Katayama; Toshiaki Iba; Masanori Matsumoto
Journal:  Thromb J       Date:  2018-07-11

Review 4.  Combined liver-kidney transplantation for rare diseases.

Authors:  Mladen Knotek; Rafaela Novak; Alemka Jaklin-Kekez; Anna Mrzljak
Journal:  World J Hepatol       Date:  2020-10-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.